A new study published in the journal Molecular Psychiatry by a team led by Salah El Mestikawy, Ph.D., researcher at the Douglas Mental Health University Institute (CIUSSS de l’Ouest-de-l’île-de-Montréal), professor at McGill University and head of research at CNRS INSERM UPMC in Paris, opens the field to new understanding of the molecular mechanism underlying addiction in humans.
Mimi Israël, MD, and Serge Beaulieu, MD, PhD received a 2013 “Coup de chapeau verdunois” for their commitment as first-line psychiatrists. The awards were handed out by Roger Cadieux, President of the Forum économique de Verdun, during a recognition ceremony on the evening of November 27.
This award recognizes the involvement of Verdun residents and employees.
Salah El Mestikawy, PhD, a researcher at The Douglas Institute, along with his research team, have received $1.5 million to explore the dual signalling capacity of neurons. This research grant is one of five new Multi-Investigator Research Initiative (MIRI) grants awarded by Brain Canada with funds from the Canada Brain Research Fund and Partners. The Douglas team will work with colleagues at the University of Western Ontario.